In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Shiseido's Decleor Stake Signifies Aromatherpy Market Commitment

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Shiseido's acquisition of French spa company Decleor indicates the Japanese cosmetics firm's dedication to the aromatherapy market as well as its long-standing global multibrand strategy. Shiseido purchased a 75% stake in the company in a deal announced May 15.

You may also be interested in...



Decleor Facial Cleansers Relaunch With Fresh, Modern Formulas

French firm Decleor is relaunching its aromatherapy facial cleansing category as one effort intended to help drive double-digit growth in 2003, according to the Shiseido subsidiary

Decleor Facial Cleansers Relaunch With Fresh, Modern Formulas

French firm Decleor is relaunching its aromatherapy facial cleansing category as one effort intended to help drive double-digit growth in 2003, according to the Shiseido subsidiary

Shiseido Carita Skin Care Slated For U.S. Spa Distribution

Shiseido will introduce French skin care lineCarita in selective U.S. high-end spas in spring 2002, the company said

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure

South Korea Sees Pharma Leadership Transition

FDA-EMA Advice Pilot For Complex Generics: What Does Industry Have To Say?

The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’

See All
UsernamePublicRestriction

Register

RS008056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By